aTyr Pharma | LIFE - Ebit


aTyr Pharma reported $-226.49K in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Ardelyx USD 7.12M 19.62M Sep/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 2.75B 1.35B Dec/2024
Curis USD -12.37M 230K Sep/2023
Galapagos EUR -41.67M 15.35M Sep/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 411.56M 15.51M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Xoma USD -10.08M 4.4M Jun/2024